AESGP Programme

Barcelona
26-28 May 2015

Hilton Diagonal Mar
Citizen
empowerment:
A megatrend
of the 21st century
51st AESGP Annual Meeting
Conference programme
and list of participants
AESGP Programme_56pp_V3.indd 1
20/05/2015 16:32
AESGP CONFERENCE ON YOUR MOBILE

Download aesgp2015
Speakers
bios
What is
discussed
and when
Who is
at the
conference
Ask questions
to speakers
Available presentations are uploaded at aesgp.eu/p51
20/05/2015 16:32
Hilton WiFi
Username: AESGP
Password: aesgp2015
Table of content
Programme overview
Conference area
Opening event
Sessions | Speakers and background information
12
Closing event
39
Next AESGP Conferences
41
Medicines and Medical Devices Data Bank
42
Food Supplements Data Bank
44
List of participants
46
Get your badge from the AESGP Welcome Desk:

Open
0D\_

0D\_RQZDUGV
0D\_

0D\_
)R\HURIWKH+LOWRQ'LDJRQDO0DU(see floorplan p6)

(QWUDQFHRI&DVD/ORWMDGH0DURSHQLQJHYHQW
)R\HURIWKH+LOWRQ'LDJRQDO0DU
)R\HURIWKH+LOWRQ'LDJRQDO0DU
Simultaneous translation
The conference languages are English and Spanish. Simultaneous translation in
French will be provided.
Conference
20/05/2015 16:32
Programme
Wednesday
27 May 2015
09:00-10:30
11:00-12:30
Consumer Health Industry: how

to provide the best service?
New technology - new guidance better self-care
Pedro NuenoProfessor in the Department

of Entrepreneurship, IESE Business School
and Professor and President, CEIBS
(Shanghai, Beijing)
Brian McNamara, Head of Americas

and Europe, GSK Consumer Healthcare
Ryan Olohan, Industry Director,
Healthcare, Google Inc
Sastry Chilukuri, Principal,
McKinsey&Company
Didier Deltort, Global Monitoring
Solutions General Manager, General
Electrics Healthcare, Finland
Carlos Lens,Ministry of Health, Spain
Global perspectives on Citizen

Empowerment: What I would
change if I could
Roger Scarlett-SmithAESGP President
Andy TismanIMS Health
Dagmar Roth-BehrendtFormer Member
of the European Parliament
Thursday
28 May 2015
10:30-11:00 Break
12:30-14:00 Lunch
09:00-10:30
11:00-12:30
Self-care medical devices and

food supplements: New drivers
for the self-care market?
Hubertus Cranz, AESGP Director General
Valeriu Curtui, Head of the Nutrition Unit,
European Food Safety Authority (EFSA)
Gwenole Cozigou, Director, DG GROW,
European Commission
Werner Knoess, Chair, Herbal Medicinal
Products Committee (HMPC), European
Medicines Agency (EMA)
Switching: A mega trend?

Suneet Varma, President, Consumer
Healthcare, Pfizer
Erin Gainer, Chief Executive Officer, HRA
Pharma
Darragh OLoughlin, President,
Pharmaceutical Group of the European
Union (PGEU)
Beln Crespo, Agency for Medicinal
Products and Medical Devices, Spain
Conference
20/05/2015 16:32
Programme
re
HRA
14:00-15:30
16:00-17:30
How to make health care affordable?
The new European Union platform

for the promotion of self-care
systems
Jaume Pey,Director General, anefp, Spain

Peter Schneider, Researcher, Austrian
Health Institute
Laura Pellis, Senior Researcher Center for
Research in Health and Economics (CRES) at
the University Pompeu Fabra (UPF),
Barcelona
Toni Gilabert, Director of Pharmacy
Management and Pharmacoeconomics,
Catalonia Health Department
Nikos Maniadakis, Associate Dean,
National School of Public Health, Greece
Rosa Suol,Director General, Avedis Donabedian

Institute, Barcelona
Birgit Beger, Secretary General of the Standing
Committee of European Doctors (CPME)
Cristina CabritaSenior Project Officer, Portuguese
Consumer Organisation (DECO) on behalf of the
European Consumer Organisation (BEUC)
Carmen PeaPresident, International Pharmacists
Federation (FIP)
15:30-16:00 Break
17:30 End of 1st day
14:00-15:45
16:15-17:15
How to ensure availability of

safe products?
Perspectives for the future
Vincent Warnery, Senior Vice President,

Global Consumer Healthcare Division, Sanofi
Natalie Gauld, Director, Pharmacy Projects
and
Alison van Wyk, Professional Services
Manager, Green Cross Health, New Zealand
Sarah BranchMedicines and Healthcare
Products Regulatory Agency (MHRA), United
Kingdom
Beln Escribano, Agency for Medicinal
Products and Medical Devices, Spain
Stefano Soro, European Commission
15:30-16:00 Break
Roger Scarlett-SmithAESGP President

Peter Liese, Member of the European Parliament
Noel Wathion, European Medicines Agency (EMA)
Invitation to the 52nd AESGP Annual Meeting 31
May 2 June 2016 in the Divani Apollon Hotel,
Vouliagmeni, Athens, Greece
George Dokios, Executive Director, Association of
the Greek Self-Care, Industry, EFEX
19:00 Closing dinner
Conference
20/05/2015 16:32
Hilton Diagonal Mar

Conference area
Ground floor
Lift to rooms
Entrance to
the hotel
Hotel reception
Entrance to the
conference area
Conference hall
Foyer / Coffee station
AESGP
Welcome Desk
WiFi
Username: AESGP
Password: aesgp2015
Conference
20/05/2015 16:32
Hilton Diagonal Mar
Floor 1
Lift to rooms
Hotel restaurant
* In case of bad weather, lunch on 27 and 28 May 2015 will be served in the hotel restaurant on the 1st floor
Conference
20/05/2015 16:32
Hilton Diagonal Mar

Conference area
Floor 2
Pergola / Terrace*
* If weather permits, lunch on 27 and 28 May 2015 will be served on the terrace located on the 2nd floor
Conference
20/05/2015 16:32
Opening event
Tuesday 26 May 2015

18:30
Departure of buses from the Hotel Hilton Diagonal Mar
19:00
Reception in the neoclassical courtyard of the Casa Llotja de Mar
20:00
Welcome by Roger Scarlett-Smith, AESGP President
Jordi Ramentol, President anefp, CEO Ferrer
Cristina Iniesta, Health Delegate of City Council & President, Public Health Agency,
Barcelona
Agustin Rivero, Director General, Ministry of Health, Spain
Boi Ruiz, Minister of Health, Catalonia
followed by dinner
22:30
Return by buses
Dress code: Business
Conference
20/05/2015 16:32
Casa Llotja de Mar
The Casa Llotja de Mar will provide an outstanding setting for the start of
the event. It is located on the sea front in the historical center of Barcelona
and is one of the most significant and splendid monuments representing
the economy and culture of the city.
It was built in the second-half of the 14th century, the most brilliant period
of Catalan Gothic and served as the citys medieval stock exchange (more
affectionately known as La Llotja). The centrepiece of the premise is the fine
Gothic Sal de Contractacions (Contracts Hall), where the opening dinner
of the 51st AESGP Annual Meeting will take place.
These and five other halls were encased in a neoclassical shell in the 18th
century. The stock exchange was in action until well into the 20th century
and the building remains in the hands of the citys chamber of commerce.
Roger Scarlett-Smith
President AESGP, GSK Consumer Healthcare
Roger Scarlett-Smith graduated with a Master in Law from St. Johns
College, Cambridge University. He started his career as a graduate
recruit in marketing at Procter and Gamble. He joined GlaxoSmithKline
Consumer Healthcare in 1984. His roles included running the Consumer
Healthcare businesses in the UK, Australia and New Zealand as well as
North America, and Europe. He also served as President of the Proprietary Association of Great Britain (PAGB). He has been serving as President of AESGP since July 2014.
10
Conference
20/05/2015 16:32
Biographies
Jordi Ramentol
President anefp, CEO Ferrer
Jordi Ramentol has a Degree in Chemistry and a Global Executive MBA
from IESE and the Internationales Fhrungsprogram. +H KDV H[WHQVLYH
experience in the pharmaceutical and chemical industries, including 25
years in BASF Group. Before joining Ferrer in 1999, he worked as Managing Director of Laboratorios Lacer. In Ferrer, he held the position of
Managing Director before becoming CEO in 2004. From 2010 to 2012, he
was the President of Farmaindustria, and he is, at present, the President
of ANEFP, the Spanish Consumer Healthcare Association, a position
which he has hold since October 2012.
Cristina Iniesta
Agustin Rivero
Health Delegate of
City Council &
President, Public
Health Agency,
Barcelona
Director General,
Ministry of Health,
Spain
Boi Ruiz
Minister of Health, Catalonia
Boi Ruiz qualified as a doctor at the University of Barcelona, and received a diploma in hospital management from Barcelona's EADA Business
School.He trained in orthopedic surgery and traumatology at Barcelona's Hospital Clinic and practiced at a number of public hospitals in
Catalonia. Later, he held a range of managerial positions in Catalonia's
National Health Service. As a health and healthcare expert, he has been
a member of the Spanish Congressional Subcommittee on Health and
Consumer Affairs for the Consolidation and Modernization of the National Health and has appeared as an expert witness on a number of
occasions before healthcare committees in the Catalan Parliament, the
Spanish Congress, and the Spanish Senate. . Mr Ruiz was appointed
Minister of Health of Catalonia in 2010.
Conference
11
20/05/2015 16:32
Session 1
Wednesday 27 May 2015

09:00-10:30
Consumer Health Industry: How to provide the best service?

An overall perspective for the consumer health industry will be provided by
a distinguished expert of a leading management school.
Pedro Nueno, Professor in the Department of Entrepreneurship, IESE
Business School and Professor and President, CEIBS (Shanghai, Beijing)
Global perspectives on Citizen Empowerment:

What I would change if I could
Representatives from market research, industry and politics will discuss
where we stand with self-care and citizen empowerment and what needs to
be done to make progress in the future.
Roger Scarlett-Smith, AESGP President
Andy Tisman, IMS Health
Dagmar Roth-Behrendt, Former Member of the European Parliament
10:30 - 11:00 Break
12
Conference
20/05/2015 16:32
Biographies
Pedro Nueno
Professor in the Department of Entrepreneurship, IESE and Professor and President, CEIBS (Shanghai, Beijing)
Pedro Nuenos areas of specialization include entrepreneurship and starting
new ventures; management of technology and innovation: management of
privatization and turnaround processes; industrial alliances; joint-ventures
and acquisitions; industrial procurement, and supply-chain management. Mr
Nueno holds the Bertran Foundation Chair of Entrepreneurship at IESE and
the Chengwei Ventures Chair on Entrepreneurship at CEIBS.
Andy Tisman
Senior Principal, Consumer Health, IMS Health.
Before joining IMS, Andy Tisman was Managing Consultant at a healthcare
strategy and marketing consultancy boutique based in the UK. He worked
around the world for major clients such as Bayer, Novartis, Pfizer, SanofiAventis and GlaxoSmithKline, and has extensive experience of brand/ category strategy development. He also has extensive Pharma and OTC/ Consumer Health marketing management experience from over 15 years with
SmithKline Beecham in local and international (pan-European and global)
roles. He joined IMS in 2005 as Senior Principal to lead the development of
the Consumer Health consulting business.
Dagmar Roth-Behrendt
Former Member of the European Parliament
Dagmar Roth-Behrendt studied law at the University of Marburg, Germany.
Between 1979 and 1989, she worked as a lawyer, and was later employed
as legal advisor in the chancellery of the Governing Mayor of Berlin. Between 1989 and 2014, Mrs Roth-Behrendt was a Member of the European
Parliament and had several key responsibilities, including: Spokeswoman of
her political group in the Committee on the Environment, Public Health
and Consumer and Vice-President of the European Parliament. She was
also a representative of the European Parliament at the High Level Pharmaceutical Forum and the contact person for the European Parliament at the
European Medicines Agency. In March 2015, Mrs Roth-Behrendt was appointed Special Advisor to the EU Health Commissioner Vytenis Andriukaitis.
Conference
13
20/05/2015 16:32
Session 2

11:00-12:30
New technology - new guidance - better self-care

This session will discuss the implications of new technologies and new media
on health information and citizens behaviour.
Brian McNamara, Head of Americas and Europe, GSK Consumer Healthcare
Ryan Olohan, Industry Director, Healthcare, Google Inc
Sastry Chilukuri, Principal, McKinsey&Company
Didier Deltort, Global Monitoring Solutions General Manager, General Electrics
Healthcare, Finland
Carlos Lens, Ministry of Health, Spain
12:30 - 14:00 Lunch
14
Conference
20/05/2015 16:32
Biographies
Brian McNamara
Head of Americas and Europe, GlaxoSmithKline Consumer Healthcare
Brian McNamara has a Master of Business Administration in finance
and a bachelors degree in electrical engineering.
He began his career at Procter & Gamble Co., Cincinnati, and joined
Novartis in 2004 as Senior Vice President and General Manager of
Novartis OTC North America. He served as President of Novartis
OTC Europe from 2007 until 2010, and was then appointed global
President of Novartis OTC until the establishment of the joint venture with GlaxoSmithKline Consumer Healthcare in February 2015.
Ryan Olohan
Industry Director, Healthcare, Google Inc
Ryan Olohan holds a bachelors in business management from Providence College. As the Industry Director for Healthcare at Google, Ryan
Olohan leads the teams responsible for developing and managing
Google's relationships with pharmaceutical and consumer health companies. Before Healthcare, Ryan spent the majority of his over six years
at Google as the Head of Consumer Packaged Goods. Outside of his
day job, Ryan is a frequent speaker at industry events and is on the
Advisory Board for the New Jersey Institute of Technology. Prior to
joining Google, Ryan was a VP at The Bank of New York Mellon, the
Director of Sales at Next Jump Inc., and got his digital education at the
search marketing agency, Reprise Media.
Sastry Chilukuri
Principal, McKinsey&Company
Sastry Chilukuri has a B. Tech from the Indian Institute of Technology
and an MBA from Kellogg School of Management, Northwestern University.
Prior to joining McKinsey, he was employed by GE Healthcare for over 6
years. He held multiple roles in product development and operations,
managing global development teams. Mr Chilukuri is now a Principal in
McKinsey and Companys New Jersey Business Technology Office, where
he focuses on strategy, technology and operations for the pharmaceutical and medical device sector.
Conference
15
20/05/2015 16:32
Biographies
Didier Deltort
Global Monitoring Solutions General Manager, General Electrics
Healthcare, Finland
Didier Deltort has a degree in Biomedical Engineering
from UTC
Compiegne. He spent his entire career in healthcare medical devices,

diagnostic imaging and IT. His latest position at GE Healthcare included:
European GM Life Care Solutions, EMEA Computed Tomography GM,
Middle-East, Africa, Turkey and Central Asia GM. His current position is
Global General Manager of GE Healthcare Monitoring Solutions. He is
also leading the General Electrics Healthcare operations in Finland.
Carlos Lens
Ministry of Health, Spain
Carlos Lens holds a degree in Pharmacy and in Economy/Business
Administration, as well as a PhD in Pharmacology. Previously , Mr Lens
had several top management position in pharmaceutical companies.
Since 1996, he has had different positions such as Secretary-General and
Director of the Spanish Agency for Medicines and Healthcare Products,
Board Member of the European Medicines Agency (EMA), and Director of
the Centre for the Coordination of Ethics Research Committees. In 2012,
he took over the responsibility as Deputy Director General of Medicines
and Healthcare Products at the Spanish Ministry of Health.
16
Conference
20/05/2015 16:32
Session 3

14:00-15:30
How to make health care affordable?

Numerous studies carried out over the last years show the economic and social
value of self-care. This session will present the results of new work done on a
pan-European level as well as in Spain and Greece. Participants will get insight in
new methodologies applied which should be helpful for all kind of similar work in
the future.
Jaume Pey, Director General, anefp, Spain

Peter Schneider, Researcher, Austrian Health Institute
Laura Pellis, Senior Researcher Center for Research in Health and
Economics (CRES) at the University Pompeu Fabra (UPF), Barcelona
Toni Gilabert, Director of Pharmacy Management and
Pharmacoeconomics, Catalonia Health Department
Nikos Maniadakis, Associate Dean, National School of Public Health, Greece
15:30-16:00 Break
Conference
17
20/05/2015 16:32
Biographies
Jaume Pey
Executive Director, anefp, Spain
He holds a Degree in Business Administration and a Master Degree from
the University of ESADE. He began his professional career in the pharmaceutical sector at Sanofi, moving on to Bayer, where he worked as Pharmacy Sales and Marketing Director. In November 1997, he joined the
agency Olgilvy One as deputy general director, and a year and a half later
he became director of OTC Division of Novartis, a job that he held for
five years until he joined Zambon as general director for the Iberian Peninsula, where he remained until September 2012. Since November 2012
he manages the Spanish Association for the self-care products (anefp).
Peter Schneider
Researcher, Austrian Health Institute
Peter Schneider studied Economics at the University of Vienna, Austria.
After his graduation in 2010 he got a scholarship for the Erasmus Mundus Master Programme Economics of International Trade and European
Integration (EITEI), hosted by the Staffordshire University, UK, the University of Antwerp, BE and the University of Economics in Prague, CZ. In
his master thesis, he examined the effects of political and economic integration on self-assessed well-being in Central European countries. Since
2011, Peter has been doing his PhD at the University of Graz, Austria. He
joined the Health Economics Department at the Austrian Health institute
in 2014 and has worked on access to high-cost and specialised medicines, pricing and reimbursement of medicines, and comparison between
health systems.
Laura Pellis
Director and Senior Research Fellow of the Centre for Research in Health
and Economics (CRES).
Graduated in Economics at the University of Barcelona, Laura Pellis
holds a MSc in Health Policy and Management from Harvard University and a Ph.D. in Economics from Pompeu Fabra University. She joined
CRES-UPF in 2011, bringing together a sound knowledge of the Spanish
health care and biomedical arenas, and her management, teaching and
research skills. Between 2011 and 2013, she was CRES Director. She is
the co-director of the Master in Health Service Administration and Management, jointly organised by the Continuing Education Institute of the
UPF and the Gaspar Casal Foundation of Madrid, and of the
"Postgraduate Diploma in Clinical Management", organised by the same
foundation in collaboration with the Barcelona School of Management
(BSM-UPF).
18
Conference
20/05/2015 16:32
Biographies
Antoni Gilabert
Director of Pharmacy Management and Pharmacoeconomics, Catalonia Health Department
Antoni Gilabert holds a PhD in Pharmacy and a Masters Degree in
Public Health (University of Barcelona). He previously was the Head
of Division of Pharmaceutical Care and Complementary Services,
Catalan Health Service. Before that, he was responsible for
Pharmaceutical Control and Drug Information. He had different
positions, as a pharmacist in the Pharmaceutical Planning Service,
as a researcher in pharmacology (Ferrer Internacional S.A.
laboratory), and in immunology (Pharmacy Faculty, University of
Barcelona). He is now the Director of Pharmacy Management and
Pharmacoeconomics, Catalonia Health Department.
Nikos Maniadakis
Associate Dean, National School of Public Health, Greece
Nikos Maniadakis is a Professor of Health Services Organisation
and Management and Associate Dean of the National School of
Public Health in Greece. He studied Economics at the University of
Athens, Health Economics at the University of York and Business
Administration at Warwick Business School. Mr Maniadakis started
his career as a Research Fellow at the Health Economics Research
Centre of Oxford University and then moved on to take leading
international positions in the pharmaceutical and the health care
industry.
Conference
19
20/05/2015 16:32
Session 4

16:00-17:30
The new European Union platform for the

promotion of self-care systems
In order to make progress in the wide promotion of self-care, a close cooperation with all relevant stakeholders is a key prerequisite. Such cooperation has
become far more intensive over the last years and is now supported and facilitated by the new European Union (EU) project on the promotion of self-care systems, which is an extension of the work on good governance of non-prescription
medicines carried out under the mandate of the previous European Commission.
The session will give an update of the new EU project and discuss how to make
the new platform relevant for the European citizens.
Rosa Suol, Director General, Avedis Donabedian Institute, Barcelona

Birgit Beger, Secretary General of the Standing Committee of European
Doctors (CPME)
Cristina Cabrita, Senior Project Officer, Portuguese Consumer Organisation
(DECO) on behalf of the European Consumer Organisation (BEUC)
Carmen Pea, President, International Pharmacists Federation (FIP)
17:30 End of 1st day
20
Conference
20/05/2015 16:32
Biographies
Rosa Suol
Director General, Avedis Donabedian Institute, Barcelona
Rosa Suol is the Director of Avedis Donabedian Institute Autonomous University of Barcelona (FAD). She is also the Deputy Editor of
the International Journal for Quality in Health Care since 1991. She
has published several articles and books and has over 25 years of
experience in health and social care research on quality of, as well as
implementing more than 230 internal quality programs in Spain. Ms
Suol has participated in several EU funded research projects such as
MARQuIS and DUQuE and she co-ordinates the EU project
EMPATHIE: Empowering patients in the management of chronic
diseases.
Birgit Beger
Secretary General of the Standing Committee of European Doctors
(CPME).
Birgit Beger is a registered lawyer in Berlin and Brussels and holds
degrees in law and political science from the Freie Universitt Berlin.
She has been working for over ten years in Public Affairs and Law in
Brussels, inter alia with the European Parliament, a law firm and a
European Umbrella Organisation in the area of human rights and
social policy. Before her position as CPME Secretary General, Ms Beger
was Senior Legal advisor at the Council of Bars and Law Societies of
Europe (CCBE) responsible inter alia for Information Technology Law
and European Contract Law.
Conference
21
20/05/2015 16:32
Biographies
Cristina Cabrita
Senior Project Officer, Portuguese Consumer Organisation (DECO) on
behalf of the European Consumer Organisation (BEUC)
Pharmacist by training, Cristina Cabrita holds a Master in Public
health in the field health promotion and education and finishing a
Master in Epidemiology. Cristina joined the Portuguese Consumer
Organization (DECO) in 2004. As senior project officer at DECO
Cristina has daily contacts with consumers and provides them with
information and advice on health related issues. Cristina represents
DECO in relevant fora at national level and also represents the European Consumer Organization (BEUC) at EU level (e.g. European
Medicines Agency Pharmacovigilance Committee).
Carmen Pea
President, International Pharmacists Federation (FIP)
Carmen Pea is a Spanish pharmacist. She was elected President
of the International Pharmaceutical Federation (FIP). As a community pharmacist from Madrid, Ms Pea has served FIP for more
than 20 years, including being Vice-President since 2008. She is
currently president of the General Pharmaceutical Council of
Spain. Ms Pea, who is the first woman and first pharmacist from
Spain to be elected as President in the FIPs 102-year history, took
office on 5 September 2014 for a presidency term of four years.
22
Conference
20/05/2015 16:32
Session 5
Thursday 28 May 2015

09:00-10:30
Self-care medical devices and food supplements:

New drivers for the self-care market?
Substance-based, self-care medical devices and food supplements have become
an important part of self-care. However, their regulatory future is uncertain. The
current revision of the medical device legislation addresses the adequate future
legal basis for substance-based medical devices with different approaches under
consideration. In the area of food supplements, the evaluation of botanical claims
continues to be put on hold with uncertainties for the whole marketplace including in particular herbal medicinal products, for which an elaborated system has
been put in place in the European Union. The session will give an overview on
where the debate stands and what the likely future environment will be.
Hubertus Cranz, AESGP Director General

Valeriu Curtui, Head of the Nutrition Unit, Head of the Nutrition Unit, European
Food Safety Authority (EFSA)
Gwenole Cozigou, Director, DG GROW, European Commission
Werner Knoess, Chair, Herbal Medicinal Products Committee (HMPC),
European Medicines Agency (EMA)
15:30-16:00 Break
Conference
23
20/05/2015 16:32
Biographies
Hubertus Cranz
Director General, AESGP
Hubertus Cranz has Masters degrees in Pharmacy and Economics and obtained a Doctorate in Natural Sciences at the University of Kiel, Germany. After taking part in different trainee programmes in pharmacies and the pharmaceutical industry (Ciba,
Bayer), he worked for the Institute for Health System Research in
Kiel, a collaborating centre of the World Health Organization
(WHO), and for the German Association of the Pharmaceutical
Industry (BPI) in Frankfurt. Afterwards, he became Director General of AESGP and established an organization in Brussels representing the full range of the European consumer health industry.
Valeriu Curtui
Head of the Nutrition Unit, European Food Safety Authority (EFSA)
Valeriu Curtui holds a PhD in Veterinary Medicine, and his
teaching and research activity focused on toxicology and chemical food safety. Prior to his employment with the European Food
Safety Authority (EFSA), he was an academic at the Justus Liebig
University in Giessen (Germany) and at the University of Agricultural Sciences and Veterinary Medicine of Timisoara (Romania).
Valeriu joined EFSA in 2008 as a scientific officer working on chemical occurrence in food and dietary exposure and took up his
current role as Head of the Nutrition Unit in 2013. His role is to
manage the Unit in providing scientific and administrative support to the EFSA Scientific Panel on Dietetic Products, Nutrition
and Allergies (NDA Panel). The NDA Panel deals with questions
related to dietetic products, human nutrition and food allergies as
well as associated subjects such as scientific substantiation of
health claims and safety of novel foods.
24
Conference
20/05/2015 16:32
Biographies
Gwenole Cozigou
Director, DG GROW, European Commission
An economist by training, Gwenole Cozigou has been an official in the services of the European Commission since 1985,
primarily in the fields of Enterprise and Industrial Policy and of
External Relations.
He was Deputy Head of Office of Commissioner Liikanen and
occupied several management positions in the following
areas:
- Food Industry and Biotechnology;
- Coordination of the internal market legislation for goods;
- Enterprise and Industrial policy;
- Defence, Aerospace and Maritime Industries.
In 2008, Mr Cozigou was the Director for Chemicals, Metals,
Mechanical, Electrical and Construction Industries, Raw Materials, in the European Commission Enterprise and Industry
Directorate-General. This included the industrial policy for
pharmaceuticals. After the reorganisation of this DirectorateGeneral in 2014, his reponsibilities also cover the area of medical devices.
Werner Knoess
Chair , Herbal Medicinal Products Committee (HMPC),
Werner Knoess studied Biology with a Diploma thesis on
Natural products in marine algae in 1986. His postgraduate
studies were at the Institute for Pharmaceutical Biology at the
University of Bonn.
He is Head of the Department Complementary and Alternative Medicines and Traditional Medicinal Products at the
Federal Institute for Drugs and Medical Devices, Bonn, Germany and Chair of the European Medicines Agencys Committee for Herbal Medicinal Products (HMPC).
Conference
25
20/05/2015 16:32
Background information
Food supplements
Food supplements are concentrated
sources of vitamins and minerals and
other substances with a nutritional or
physiological effect, marketed in dose
forms. The purpose of food supplements is to supplement the normal
diet to compensate possible nutritional deficits.

At the European level, the adoption of
Food Supplements Directive in 2002
created a legal basis for food supplements, providing general advertising
and labelling principles as well as listing vitamins and minerals and their
sources authorised in food supplements.
For the time being, important elements for this market place remain
within the national responsibility, including minimum and maximum levels
of vitamins and minerals, and the permission to use other substances, i.e.
substances other than vitamins and
minerals such as herbals, fatty acids,
amino acids, probiotics.
Nutrition and health claims on food
and food supplements in the EU
Food supplements are regulated in the
EU as food and must comply with a
legislative framework applicable to
foods.
26
This includes in particular the legal

provisions on nutrition and health
claims which are often used in labelling, advertising and promotion of
food supplements and other foods.
The EU Claims Regulation was adopted
in 2006 aiming to protect the consumer from misleading or inaccurate
claims but also to allow the industry to
use truthful and scientifically substantiated claims as a competitive marketing
tool. In the EU, food supplements cannot bear claims unless they are authorised.
In order to get an EU authorisation, all
health claims must be submitted to
EFSA to undergo scientific assessment
carried out by the EFSA Scientific Panel
on Dietetic Products, Nutrition and
Allergies (NDA). A health claim dossier
shall include information on food characteristics, health relationship, conditions of use and pertinent scientific
data which form the basis for the substantiation of a claim.
Following a scientific assessment by
EFSA, health claims are authorised by
the European Commission and the EU
Member States. The authorisation decision is then subject to the scrutiny of
the European Parliament and the
Council. Authorised and nonauthorised claims are published in the
Official Journal of the EU and in the on
-line EU Register of Claims.
Conference
20/05/2015 16:32
EU definitions of nutrition and health claim made on foods and food supplements
Nutrition claim
A claim suggesting that a food has particular beneficial nutritional properties due
to:
HQHUJ\ it provides/ provides at a reduced or increased rate/ does not provide, e.g.
low energy, energy reduced, energy-free
QXWULHQWVor other substances it contains/ contains in reduced or increased proportions/ or does not contain, e.g. source of omega-3 fatty acids, low fat, sugars-free
Health claim
A claim suggesting that a relationship exists between a food and health
General function claim
A health claim referring to the role of a nutrient in growth, development and the
functions of the body, psychological and behavioural functions, slimming or weight
control, e.g.:
0DJQHVLXPFRQWULEXWHVWRQRUPDOPXVFOHIXQFWLRQ
General function claims are based either on generally accepted scientific evidence or
on newly developed scientific evidence
Reduction of disease risk claim
A health claim stating that the consumption of a food significantly reduces a risk factor in the development of a human disease, e.g.:
3ODQWVWHUROVKDYHEHHQVKRZQWRORZHUUHGXFHEORRGFKROHVWHURO+LJKFKROHVWHUROLV
a risk factor in the development of coronary heart disease
Children claim
A health claim referring to childrens development and health, e.g.:
&DOFLXPLVQHHGHGIRUQRUPDOJURZWKDQGGHYHORSPHQWRIERQHLQFKLOGUHQ
EFSA NDA Panel scientific assessment of health claims applications
Conference
27
20/05/2015 16:32
Medical devices
Substance-based medical devices include devices such as nasal sprays primarily used on sufferers, often infants
with cold symptoms and blocked nose,
denture adhesives, dentifrices for sensitive teeth, verruca and wart removers,
gels for vaginal discomfort, lozenges to
treat throat discomfort, flushing solutions, creams used to treat or prevent
minor skin irritations, anti-snoring
sprays, or anti-flatulence products acting by a chemico-physical mode of
action. They are currently placed in the
market in accordance with the essential requirements of Directive 93/42/EC
on medical devices.
European Commission
In September 2012, the European
Commission proposed two new regulations on medical devices and on in
vitro medical devices, with the intention of replacing the existing legal
framework for Medical Devices Directives.
The proposal suggested a new rule in
the Annex VII Classification criteria UHDGLQJ WKDW Devices that are
composed of substances or combination
of substances intended to be ingested,
inhaled or administered rectally or vaginally and that are absorbed by or dispersed in the human body are in class
III (rule 21) and a point 9.2 of the
annex I General safety and perfor-
28
mance requirements GHPDQGLQJ

compliance of these devices with the
relevant requirements laid down in
Annex I to Directive 2001/83/EC on
medicinal products.
European Parliament
Under the ordinary legislative procedure, the European Parliament and the
Council (Member States) examine the
Commissions proposal and have the
possibility to introduce amendments to
it.
The European Parliaments Committee
for the Environment, Public Health and
Food Safety, lead Committee on this
file, started discussing the proposed
regulations in 2012. The first reading
position of the European Parliament
was adopted in a plenary session in
April 2014 under the rapporteurship of
Dagmar Roth-Behrendt.
Amongst others, the report proposes
the deletion of Rule 21 in Annex VII,
and of the reference to Annex I to Directive 2001/83/EC on medicinal products.
A new European Parliaments negotiating team led by the Member of the
European Parliament and new rapporteur on the file Glenis Willmott (UK)
was appointed further to the European
Parliaments election in May 2014.
Conference
20/05/2015 16:32
Council of the EU (Member States)

The Council has been examining the
proposed regulations under the leadership of the latest six Presidencies of the
Council of the European Union, respectively Cyprus, Ireland, Lithuania, Greece,
Italy, and Latvia. The Councils preparatory body in charge of the file is the
Working Party on Pharmaceuticals
and Medical Devices composed of
representatives of the 28 Member
States Ministries of Health/ National
Competent Authorities.
New provisions on substance-based
medical devices proposed by the Latvian Presidency were discussed and examined by the Committee of Permanent Representatives (COREPER) in
March 2015, however not adopted.
These included the following Rule 21
wording:
,Q FODVV ,,E LQ DOO RWKHU FDVHV LI

WKH\ RU WKHLU SURGXFWV RI PHWDER
OLVPDUHORFDOO\GLVSHUVHGEXWQRW
DEVRUEHG E\ WKH KXPDQ ERG\
H[FHSWLIWKH\DUHDSSOLHGRQVNLQ
RU PXFRXV PHPEUDQH YLD D ERG\
RULILFH LQ ZKLFK FDVH WKH\ DUH LQ
FODVV,,D
As of May 2015, the Council Working

Party is still discussing provisions related to Rule 21. No conlusion has
been reached yet.
Next steps
The aim of the Latvian EU Presidency is
to reach a general agreement on the
proposed regulation prior to the end of
its term by the end of June 2015.
So-called trilogue discussions on a

compromise between the European
Parliament, the Council of the European
Devices that are composed of sub- Union (Member States) and the Comstances or combinations of substances mission could possibly start under the
WKDW DUH intended to be LQWURGXFHG Luxembourg Presidency of the EU
LQWRWKHKXPDQERG\YLDDERG\RUL (from 1 July 2015 to 31 December
ILFH LQMHFWHG IRU ORFDO HIIHFW RU DS 2015).
SOLHG RQ VNLQ RU PXFRXV PHPEUDQH
and that are absorbed by or ORFDOO\ Once adopted and published in the
Official Journal, the regulations will be
dispersed in the human body are:
directly applicable in all EU Member
In class III LIWKH\RUWKHLUSURGXFWV States. No further implementation proRI PHWDEROLVP DUH V\VWHPLFDOO\ cess will be needed.
DEVRUEHGE\WKHKXPDQERG\
Conference
29
20/05/2015 16:32
Session 6

10:30-12:30
Switching: A mega trend?
Is the move of medicines from prescription to non-prescription slowing down

or speeding up? How important is it for the future of self-care? What needs to
be done to be successful?
These are key questions for many executives in the consumer health industry.
The session will follow up on the 2014 London conference and expose recent
positive developments and what needs to be done to keep the momentum.
Suneet Varma, President, Consumer Healthcare, Pfizer

Erin Gainer, Chief Executive Officer, HRA Pharma
Darragh OLoughlin, President, Pharmaceutical Group of the
European Union (PGEU)
Beln Crespo, Agency for Medicinal Products and Medical Devices,
Spain
12:30-14:00 Lunch
30
Conference
20/05/2015 16:32
Biographies
Suneet Varma
President, Consumer Healthcare, Pfizer
Suneet Varma received his Master of Business Administration from
the Harvard Business School and a Bachelor of Science in Engineering from Tufts University. Since joining American Home Products Corporation in 1993, Mr. Varma has worked in consumer
healthcare, prescription pharmaceuticals and the corporate headquarters of the company. Most recently he was Regional President, North America, for Pfizer Consumer Healthcare. His previous
roles include Regional President, Asia Pacific and President of
Pfizer Consumer Healthcare in Canada. In all his roles, Suneet has
been a champion of consumer access to innovative self-care products.
Mr. Varma served on the boards of the Consumer Healthcare
Products Association (CHPA) and the World Self-Medication Industry (WSMI).
He is now President and General Manager of Pfizer Consumer
Healthcare, and is responsible for all aspects of the business units
global operations.
Erin Gainer
Chief Executive Officer, HRA Pharma
Erin Gainer holds a bachelor's degree in biology and in English and
a master's degree in public health. She has a Ph.D. in epidemiology
from the University of Paris XI and completed her MBA for Executives at INSEAD.
Erin Gainer has been HRA Pharma's Chief Executive Officer and
President of the Executive Board since 2009. Erin joined HRA Pharma in 2000 to lead the development of the new chemical entity,
ulipristal acetate through the EMA and FDA approval processes. As
Executive Director of Research and development, she built the
company's crossdisciplinary R&D capacities up from the ground.
Conference
31
20/05/2015 16:33
Biographies
Darragh OLoughlin
President, Pharmaceutical Group of the European Union (PGEU)
Darragh OLoughlin graduated in 1993 from a School of Pharmacy. After university, he worked in hospital pharmacies and in
community pharmacy. He has operated his own pharmacies for
the last fifteen years. He is currently the President of the Pharmaceutical Group of the European Union (PGEU), having been its
Treasurer since 2013. Darragh is Secretary General of the Irish
Pharmacy Union since 2013 and was previously its President
(2010 2012). He has also previously served on both the Board
of the Health Information & Quality Authority (HIQA) in Ireland
and the Council of the Pharmaceutical Society of Ireland (PSI),
having been appointed by successive Irish Ministers for Health.
Beln Crespo
Agency for Medicinal Products and Medical Devices, Spain
Beln Crespo holds a Masters degree in Health Administration and a Bachelor of Sciences in pharmacy. She has been
Executive Director of the Spanish Medicines Agency since
2010. She previsouly held different positions such as: Deputy
Director of Alert System and Official Controls at the Spanish
Food Safety and Nutrition Agency; Head of Area of Pharmacy
Management in Primary Attention; Head of the Department
of the Studies and Control of the Offer of Medicines and
Effects and Accessories, and Pharmaceutical Inspector at the
National Institute of Public Health Care, Central Services in
Spain.
32
Conference
20/05/2015 16:33
Session 7

14:00-15:45
How to ensure availability of safe products?
Over the last years, there has been an unprecedented increase in discussions
about safety issues on the European level, the so-called referral procedures.
Questions were raised as to whether all these procedures are justified and if they
do not unnecessarily question existing products and hamper the move to nonprescription status. The session will also look at the intensive ongoing work in
relation to the implementation of the directive on falsified medicines with potentially considerable implications in the marketplace.
Vincent Warnery, Senior Vice President, Global Consumer Healthcare

Division, Sanofi
Natalie Gauld, Director, Pharmacy Projects andAlison van Wyk, Professional
Services Manager, Green Cross Health, New Zealand
Sarah Branch, Medicines and Healthcare Products Regulatory Agency (MHRA),
United Kingdom
Beln Escribano, Agency for Medicinal Products and Medical Devices, Spain
Stefano Soro, European Commission
15:30-16:00 Break
Conference
33
20/05/2015 16:33
Biographies
Vincent Warnery
Senior Vice President, Global Consumer Healthcare Division,
Sanofi
After graduating from the Ecole Superieure des Sciences
Economiques et Commerciales in 1991, Vincent Warnery joined
Procter & Gamble France where he took on various marketing
responsibilities. In 1996, he joined LOreal where he spent the
next 15 years. After a promotion to Europe Marketing Director
Garnier/Maybelline in 1998, he took over several General management responsibilities in Portugal, Germany, Latin America
and Japan. He came back to France in 2008 and took over the
responsibility of LOreal Paris France and later LOreal Cosmetique Active Division. He joined Sanofi as Vice President Consumer Health Care Europe and Global Development in 2011.
Natalie Gauld
Director of Pharmacy Projects, former member of the New Zealand, Medicines Classification Committee
A pharmacist by background, Natalie Gauld has worked in
community pharmacy, industry, research and education and
obtained a PhD examining why countries vary in prescription
to non-prescription switch of medicines.
She was a member of the New Zealand Medicines Classification Committee from 2004-2009 and has subsequently driven
switches in New Zealand in influenza vaccination and the firstin-world switches of calcipotriol and trimethoprim. Today, she
is the director of Pharmacy Projects.
Alison van Wyk

Professional Services Manager, Green Cross Health
Alison van Wyk is a nurse and work in sales, marketing and
country management in both the pharmaceutical and medical
device market both in New Zealand and internationally. Further
to that she has eight years experience in the New Zealand
pharmaceutical and medical logistics industry. Alison together
with Natalie Gauld from Pharma Projects recently won the clinical services of the year award at the 2013 Pharmacy Awards.
Alison joined the Pharmacybrands business in October 2010.
34
Conference
20/05/2015 16:33
Biographies
Sarah Branch
Medicines and Healthcare Products Regulatory Agency (MHRA),
United Kingdom
Sarah Branch has worked at the Medicines and Healthcare products
Regulatory Agency (MHRA) and its predecessor, the Medicines Control Agency, for over 20 years after lecturing in Pharmacy at the University of Bath, UK. She is a qualified pharmacist and has previously
assessed pharmaceutical aspects of new licence applications. She
moved into management in 2001, initially looking after a team responsible for licence variations but then with broader roles in the
Division responsible for pharmacovigilance. Sarah continues to manage the team responsible for paediatric procedures under the EU
Regulation and is now Deputy Director of the Vigilance and Risk
Management of Medicines Division.
Beln Escribano
Agency for Medicinal Products and Medical Devices, Spain
Beln Escribano holds a PhD in Pharmacy and a degree in Hospital
Pharmacy, as well as a Masters in Public Health. After working in the
National Health System as an hospital pharmacist, she moved to the
Health and Consumers Affairs Department of the Regional Government of Madrid. Then, she moved to the Spanish Agency for Medicinal Products and Medical Devices (AEMPS), and since then has been
responsible for its Pharmaceutical Inspection and Enforcement Department. Nowadays she is the Head of the Pharmaceutical Inspection and Enforcement Department of the AEMPS. She is also actively
involved in the implementation of the falsified medicines directive at
national level.
Stefano Soro
European Commission
Stefano Soro holds a degree in Management and Economics with a
major in human resources management from Universit Bocconi in
Milan.
Mr Soro joined the European Commission in 1994, serving successively in a variety of posts in labour statistics, enterprise policy, internal coordination and Commission reform. In 2002, he moved to
the Consumer Affairs Directorate. In September 2006, Stefano Soro
was appointed Head of the "Product and service safety" unit, responsible for non-food consumer safety issues. He is today Head of
Unit Medicinal Products - Quality, Safety and Efficacy at the Directorate General Health and Food Safety
Conference
35
20/05/2015 16:33
Session 8

16:15-17:15
Perspectives for the future
The final session will allow a discussion on the future of citizen empowerment and
selfcare with a focus on the priorities of the new European Parliament in the given
context.
Roger Scarlett-Smith, AESGP President

Peter Liese, Member of the European Parliament
Noel Wathion, European Medicines Agency (EMA)
17:15
Invitation to the 52nd AESGP Annual Meeting 31 May 2 June 2016 in the Divani
Apollon Hotel, Vouliagmeni, Athens, Greece
George Dokios, Executive Director, Association of the Greek Self-Care Industry,

EFEX, Greece
36
Conference
20/05/2015 16:33
Biographies
Roger Scarlett-Smith
President AESGP, GSK Consumer Healthcare
Roger Scarlett-Smith graduated with a Master in Law from St. Johns
College, Cambridge University. He started his career as a graduate
recruit in marketing at Procter and Gamble. He joined GlaxoSmithKline
Consumer Healthcare in 1984. His roles included running the Consumer
Healthcare businesses in the UK, Australia and New Zealand as well as
North America, and Europe. He also served as President of the Proprietary Association of Great Britain (PAGB). He has been serving as President of AESGP since July 2014.
Peter Liese
Member of the European Parliament
Peter Liese has a doctorate in medicine from the Institute of Human
Genetics at Bonn University. He worked in Central America (public
hospital and development aid projects). He became a local councilor
in Bestwig (Germany) in 1989 and he was elected as Member of the
European Parliament in 1994. During his terms in the European
Parliament, he was appointed chairman of the bioethics working
party of his political group EPP (European Peoples Party), and EPPCoordinator in the Committee on the Environment, Public Health
and Food Safety.
Conference
37
20/05/2015 16:33
Biographies
Noel Wathion
Nol Wathion is a qualified pharmacist from the Free University of Brussels. He first worked as pharmacist in a retail
pharmacy. He was later appointed to the Pharmaceutical
Inspectorate (Ministry of Social Affairs and Public Health) in
Brussels as a Chief Inspector. He is a former Belgian Member
of both the CPMP (Committee for Proprietary Medicinal Products) and CVMP (Committee for Veterinary Medicinal Products), and representative on the Pharmaceutical Committee,
Standing Committee and Notice to Applicants working
group.
He joined the EMEA (European Medicines Evaluation Agency) in 1996 as Head of Sector for Regulatory Affairs and
Pharmacovigilance and was then appointed Head of the
Human Medicines Evaluation Unit. Further to the restructuring of the Unit in 2001, he was appointed Head of Unit for
the Post-Authorisation Evaluation of Medicines for Human
Use. Then following a restructuring of the EMA in 2009, he
was appointed Head of Patient Health Protection. He is now
Chief Policy Adviser.
George Dokios
Executive Director, Association of the Greek Self-Care Industry,
EFEX
George Dokios started his career as a sales representative in
Bristol-Myers Squibb (then Bristol Myers) and rose through
various key business positions to become the General Manager of Pharmaceuticals in the same company. In 1995, he
became the General Manager in Portugal where he served
for six years, before acquiring the same position in Greece. In
2004, Mr Dokios became the Director General of the Greek
Association of Self-Medication Industry (EFEX).
38
Conference
20/05/2015 16:33
Closing event

The conference will end with a dinner at the restaurant Barceloneta
18:30
Departure of buses from the Hotel Hilton Diagonal Mar
19:00
Dinner at the Restaurant Barceloneta
From 21:45 onwards

Return by buses
Dress code: Business casual
Conference
39
20/05/2015 16:33
Social programme

The guided tour for accompanying persons will take place on Wednesday, 27 May
2015. The tour bus will depart from the Hilton Diagonal Mar at 9.00 hours and will
return at 17.00 hours. In the morning, participants will visit the premises of
Codorniu, famous for its Cava. Lunch will be served there. This will be followed by
a visit of Gothic Barcelona: the Cathedral, Town Hall and Santa Maria del Mar.
Participants will be accompanied by an English speaking guide.
40
Conference
20/05/2015 16:33
Next AESGP conferences

14-15 October 2015
Renaissance Hotel Brussels
Substance-based medical devices:

An important part of self-care
The AESGP Conference on self-care medical devices will take place at
the Renaissance Hotel in Brussels on 15 October 2015, in conjunction
with the AESGP Annual Reception at the European Parliament on 14
October 2015.
Decision makers and high level representatives of public and regulatory
authorities will join industry experts and representatives of other
stakeholder groups at the event to review latest developments and discuss
next steps for the sector.
More information available on aesgp.eu/BRU15
15-16 February 2016
Amsterdam
AESGP Conference with the EU Heads of Medicines
Agencies (HMA) during the Dutch EU Presidency
Conference
41
20/05/2015 16:33
med.aesgp.eu
D
f
Medicines and Medical Devices Data Bank
C
The AESGP Data Bank is an online database that includes information previously found
in the AESGP studies Economic and Legal Framework (ELF) for non-prescription
medicines and Legal and regulatory Framework for Herbal Medicines.
a
e
I
c
c
i
e
42
Conference
20/05/2015 16:33

Database
functionality
Combined results appear by section
and then by country (see for
example image below).
In specific sub-sections (denoted as
tables
in
the
database),
the
combined search of more than one

country will give aggregated results
in a comparative table (see for
example image below).
Information for the European Union with applicable European legislation is also
included in the database. Table sub-sections for the European Union include by
default applicable provisions in all EU member states.
Conference
43
20/05/2015 16:33
food.aesgp.eu
Food Supplements Data Bank
The AESGP Food Supplements Databank provides key information for the industry,
national competent authorities and academia on the legal and regulatory
framework for food supplements in Europe and beyond.
44
Conference
20/05/2015 16:33
eu
Conference
45
20/05/2015 16:33
51st AESGP Annual Meeting Barcelona 26-28 May 2015
International organisations
ADAMASZWILI, Kinga, Mrs
BEGER, Birgit, Mrs
BERGSTRM, Richard, Mr
BESSON, Lucas, Mr
BUA, Ornella, Ms
CABRITA, Cristina, Mrs
CHAVE, John, Mr
CHINOU, Ioanna, Prof. Dr
COZIGOU, Gwenole, Mr
CRANZ, Hubertus, Dr
CURTUI, Valeriu, Mr
DERECQUE-POIS, Monika, Mrs
DZIEKAN, Gerald, Dr
GITS, Lucy, Mrs
JENNY, Ren, Mr
KNSS, Werner, Prof. Dr
LIESE, Peter, Dr
MOUSSA, Miranda, Ms
OLOUGHLIN, Darragh, Mr
PEA, Carmen, Mrs
ROTH-BEHRENDT, Dagmar, Mrs
SCARLETT-SMITH, Roger, Mr
SORO, Stefano, Mr
TERBERGER, Martin, Dr
WATHION, Nol, Mr
AESGP
CPME
EFPIA
EPSA
AESGP
BEUC
PGEU
EMA
European Commission
AESGP
EFSA
GIRP
WSMI
AESGP
GIRP
EMA
European Parliament
AESGP
PGEU
FIP
Former Member of the European Parliament
AESGP President
European Commission
AESGP
EMA
Algeria
BENBAHMED, Lot, Mr
BENHAMDINE, Farid, Dr
BENMAKHLOUF, Majid, Mr
YOUBI, Mustapha, Mr
Conseil de lOrdre des Pharmaciens

Socit Algrienne de Pharmacie
Ministry of Health
Sano
Australia
SCHOOMBIE, Deon, Dr
ASMI
Austria
BUCHEBNER, Christine, Dr
EIBEGGER, Susanne, Mrs
FREY, Denise, Ms
GROTTENTHALER, Ulrich, Mr
GRN, Alfred, Mag.
LTSCH, Gerhard, Dr
NAGELER, Christina, Mrs & Mrs Erika SANDER
PEITHNER, Martin, Mr
PEROUTKA, Gnter, Mr
SANDOR, Stephen, Mr
SCHNEIDER, Peter, Mr
WELLAN, Max, Mr
ZOLLER, Martin, Mr
GfK Austria
Bayer Austria
Kwizda Pharma
Boehringer Ingelheim
Schuelke & Mayr
IGEPHA
IGEPHA
Austroplant
Mag. G. Peroutka
Kwizda Pharma
Austrian Health Institute
Austrian Chamber of Pharmacists
Belgium
CASSIMAN, Jan, Mr
CORONEL, Mary, Mrs
DE BAERDEMAEKER, Jurgen, Mr
46
Oystershell
IM Associates
Conference
20/05/2015 16:33
GALAND, Frdric, Mr
MARANES, Gustavo, Mr
MERTENS, Gilbert, Mr
RAEMDONCK, Nolle, Mrs
TEMPRA, Alessandro, Mr
VAN REETH, Ren, Mr
VANDIEST, Philippe, Mr
VERHAGE, Bert, Dr
VERLINDEN, Marc, Mr
WILL, Maurienne, Mrs
Promomed
Johnson & Johnson
Consultant
Promomed
Johnson & Johnson
BACHI
Promomed
Will-Pharma
Qualiphar
Will-Pharma
Brazil
MARQUES NETO, Jonas, Mr
ABIMIP
Bulgaria
PIEROVA, Mihalea, Mrs
Sano-aventis
Canada
PROUD, Karen, Ms
SKINNER, David, Mr & Mrs Karen PATRICK
Consumer Health Products Canada

Heuristix
Croatia
TODORI-KOVAEVI, Vesna, Mrs
Belupo
Czech Republic
MELNYK, Nick, Mr
Sano
Denmark
NOERUM, Helle, Ms
Fertin Pharma
Egypt
ABDELLATIF, Yasser, Mr
GHADA, Michel, Mr
HUSSIEN, Mearal, Mrs
MOHAMED, Aml, Mr
NAZMY, Noha, Mr
Ministry of Health
Sano
GlaxoSmithKline Consumer Healthcare
Ministry of Health
Sano
Finland
DELTORT, Didier, Mr
GOHLKE-KOKKONEN, Maija, Ms
VERTANEN, Janne, Mr
GE Healthcare
PIF
Oy Verman
France
ANTONIO, Manuel, Mr
BACOS, Jean-Claude, Mr
BERTRAND, Mireille, Mrs
BON, Antoine, Mr
BROCHET, Benoit, Mr
BROSSARD, Pascal, Dr
BULIDON, Valerie, Dr
BURZACCA, Giulio, Mr
CAUDWELL, Amanda, Mrs
CHETCUTI, Irne, Mrs
DE LA FOUCHARDIRE, Christophe, Mr
DECHELETTE, Lionel, Mr
DERRE, Jean-Franois, Mr
ERWIN, Cathy, Mrs
FLACHAIRE, Magali, Mrs
GAINER, Erin, Dr
GEORGAKOPOULOS, Evangelos, Mr
GUILLARD, Hlne, Mrs
Celtipharm
Bristol Myers Squibb
Sano
Urgo
Naturex
Zambon
Sano-aventis
Sano
Sano
Boiron
Sano
Pierre Fabre
Celtipharm
Sano
RB
HRA Pharma
Pzer Sant Familiale
HRA Pharma
Conference
47
20/05/2015 16:33
HELLNER, Dirk, Mr
HIRT, Eva, Mrs
INFESTA-FERNANDEZ, Josep, Mr
LECOMTE-SOMAGGIO, Daphn, Mrs
MAGLIONE, Sandrine, Mrs
MAILLARD, Eric, Mr
OSSENBERG-ENGELS, Dirk, Mr
PEYRICAL, Bernard, Mr
PRISMICH, Glaucia, Mrs
PRZYBYLSKI, Christoph, Mr
TEO, Eric, Mr
UBAYSI, Kamal, Mr
VAN RYCKE, Isabelle, Mrs
VAUCEL, Fabien, Mr
VOISIN, Sophie, Mrs
WARNERY, Vincent, Mr
WELGRYN, Frdrique, Mrs
Sano
Sano
Sano
AFIPA
AFIPA
Tonipharm
Bayer HealthCare
Sano
Sano-aventis
Pierre Fabre
Sano
Sano
Sano-aventis
Sano
Sano
Sano
HRA Pharma
FYROM
STOJANOV, Orce, Mr
VELEVSKA, Aleksandra, Mrs
Alkaloid
Alkaloid
Germany
AKBABA, Metin, Mr
BURGES, Johannes, Mr & Ms Marietta
BUSSE, Werner, Dr Dr. Willmar
CARTER, Paul, Dr
CASPAR, Susanne, Mrs
CSOKE, Emese, Dr
DETHLEFFSEN, Andreas, Mr & Mrs Christiane
DITTRICH, Heinz, Dr & Mrs Andrea
DITZEL, Peter, Mr & Mrs Reinhild BERGER
FREUDENSTEIN, Johannes, Dr
GRAF, Angela, Dr
HARTLEY, Alison, Mrs
HOFFMANN, Tino, Mr
HOLLSTEIN, Patrick, Mr
KSTNER, Uta, Dr
KEBIG, Anna Elisabeth, Dr
KOCH, Johannes, Mr
KOEPFER, Brbel, Mrs
KOLKMANN, Rainer, Dr
KORTLAND, Hermann, Dr
KRABICHLER, Gert, Dr
KROTH, Elmar, Dr
KUNZ, Stephanie, Mrs
KUSKOWSKI, Jan, Mr & Ms Tina
LASCHET, Helmut, Mr
LORENZ, Raoul, Mr
MEYER, Stefan, Mr
MIROW, Roland, Mr
MCKE, Miriam, Mrs
OEHMICHEN, Alexander, Dr & Mrs Anja
MANDELKOW
PETERSEN-BRAUN, Marianne,
Dr & Mr Joachim BRAUN
PROPPERT, Maximilian,
Mr & Mrs Maike GOFFART
PROPPERT, Yvonne, Mrs
REGENAUER, Hans, Mr & Mrs Rosemarie
REINERT, Wolfgang, Mr
48
Bayer Pharma
Hermes Arzneimittel
Schwabe
Schaper & Brmmer
Queisser Pharma
Bad Heilbrunner
Deutsche Apotheker Zeitung
BAH
Helm Medical
Apotheke Adhoc
RB
Bayer Vital
BAH
Koepfer time-to-market
Diapharm
BAH
MerckSelbstmedikation
BAH
BAH
Queisser Pharma
rzte Zeitung
Lorenz Life Sciences Group
Bayer Vital
ATKearney
Helm Medical
Dr Oehmichen & Partner
Hermes Arzneimittel
Pharma-Labor Yvonne Proppert
Pharma-Labor Yvonne Proppert
HVR-Advice
BAH
Conference
20/05/2015 16:33
REISCHIG, Dirk, Dr Dr
SANDNER, Stefan, Dr & Mrs Sabine
SCHEIFFERT, Michaela, Mrs
SCHMICKLER, Heinz-Gert, Mr
SCHOETT, Erich, Mr
SCHREPFER, Andreas, Dr & Mrs Martina
SEIPP, Joachim, Mr
SIBBING, Nicole, Mrs
SIBBING, Ralf, Mr
STEINHOFF, Barbara, Dr
STIER, Heike, Mrs
TEBROKE, Ev, Mrs
ULLRICH, Traugott, Dr
UMLAND, Thorsten, Dr
WEISER, Martin, Dr
WIECZOREK, Joerg, Mr & Mrs Waltraut
WILKE, Lilian-Susan, Mrs
WINTER, Michael, Mr
WITZEL, Wolfgang G., Mr
WRIGHT, David, Mr
Willmar Schwabe
Diapharm
Sano-Aventis
BAH
Hermes Arzneimittel
Bauer Advertising
Diapharm
Diapharm
BAH
analyze and realize
Pharmazeutische Zeitung
Dr. Willmar Schwabe
Bayer HealthCare
BAH
Hermes Arzneimittel
Wort & Bild
Egon Zehnder
Lorenz Life Science Group
Greece
DOKIOS, George, Mr
DOKIOS, Thomas, Mr
MYLONAS, Charalampos, Mr
Efex
EFEX
National School of Public Health
Hungary
CIBULYA-PALFAI, Grta, Dr
FLDHZI, Enik, Dr
SUGR, Dalma, Dr
SZRNYI, Beta, Mrs
Gedeon Richter
Egis Pharmaceuticals
RB
Sano
Israel
UVAL, Avi, Mr
Telem
Italy
ALLIEVI, Enrico, Dr
CRICELLI, Claudio,
Dr & Mrs Nadia GIANMOENA
GARLASCHINI, Renato, Dr
GAUDIOSO, Antonio, Dr
GAUXACHS, Carmen, Mrs
GIOVAGNONI, Emiliano, Dr
GIULIANI, Gianfranco, Dr
LEOPARDI, Eugenio,
Dr & Mrs Giada SPAGNUOLO
LUPARINI, Maria Rita, Mrs
MAZZOTTA, Fabio, Mr
MERCATI, Valentina, Mrs
PILLARELLA, Carla, Dr
REGNAULT, Agns, Mrs
ZUCCHETTI, Luisa, Ms
Japan
KOJIMA, Norihisa, Mr
NAKAMURA, Takatsugu, Mr
NARUSAWA, Takashi, Mr
NISHIZAWA, Motohito, Mr
SATO, Seiichi, Mr
TAGASHIRA, Yasuhiro, Mr
Assosalute
SIMG
Assosalute
Cittadinanzattiva
RB
Aboca
ACRAF
UTIFAR
E-Pharma Trento
Sano
Aboca
Assosalute
Pzer
Angelini
Kowa
Taisho
Kowa
Japan Self-Medication Industry (JSMI)
Sato Pharmaceutical
APSMI
Conference
49
20/05/2015 16:33
TANIKAWA, Masahide, Mr
TSUTSUI, Mototsugu, Mr
Kowa
Taisho
Jordan
AL-HADIDI, Iklas, Mr
BATARSA, Sohaila, Mrs
OBEIDAT, Ayel, Dr
Food and Drug Authority

Lithuania
CEKANAUSKIENE, Ausrine, Mrs
Sano-aventis
Mexico
BOLAOS, Hctor, Mr & Mrs Maria-Cristina
Afamela
Morocco
DERRAJI, Abderrahim, Mr
EL MALHOUF, Naoufal, Dr
ELKHALIFI, Omar, Mr
LAMRANI, Rachid, Mr
Fondateur Pharmacies.ma
Direction de lANAM
Cooper Pharma
Pharmacie.ma
New Zealand
GAULD, Natalie, Dr
ROPER, Richard Timothy, Mr
VAN WYK, Alison, Mrs
Pharmacy Projects
NZSMI
Green Cross Health
Norway
MAEHLUM, Marianne, Ms
Takeda
Poland
BLASZCZYK, Rafal, Mr
BLASZCZYNSKI, Witold, Mr
JURGAWKA, Robert, Mr
KRUSZEWSKA, Magdalena, Mrs
SOCHA, Elzbieta, Ms
RB
PASMI
USP
Nepentes Pharma
PASMI
Portugal
GAMINHA, Ana Beatriz, Dr
BSG Pharmaceuticals
Republic of Korea
LEE, Kyeong-Ho, Dr
KPMA
Romania
ROSIAN, Iulia, Mrs
Sano-aventis
Russian Federation
BOYTSOV, Vasily, Mr
EGOFAROV, Nail M., Mr
KILDYUSHKIN, Andrey, Mr
SHIPKOV, Vladimir, Mr & Mrs Nina SHIPKOVA
Eurasian Economic Commission

GlaxoSmithKline Healthcare
Johnson & Johnson
AIPM
Serbia
DJUROVIC, Dragan, Mr
Medicines and Medical Devices Agency of Serbia
South Africa
ZAROUDOUKAS, Natalie, Ms
Adcock Ingram
Spain
AGUADO, Carmen, Mrs
AGUADO, Mayte, Ms
ALLENDE MONCLUS, Ana, Mrs
50
Health Department Madrid Autonomous

Region
anefp
Laboratorios Dr. Esteve
Conference
20/05/2015 16:33
ALTEMIR, Javier, Mr
ARAUJO, Maria, Mrs
ARIZCUREN ZAPATER, Natalia, Mrs
ARRIOLA, Luis, Mr
AYO, Sonia, Mrs
BARELLI ARAGON, Miguel, Mr
BARRIO, Luis, Mr
BARZANO ABAD, Gema, Ms
BASOLAS TENA, Maria Carmen, Mrs
BASORA, Josep, Mr
BOSCH, Alvaro, Mr
BROCAL, Naiara, Mrs
BUENDIA SANCHEZ, Esmeralda, Mrs
BUENO GALLEGO, Alberto, Mr
CAMPOS, Jos, Mr
CAMPS MIRO, Mercedes, Ms
CARBONEL, Beatriz, Mrs
CASSANY, Salvador, Mr
CASTELL, Maria, Ms
CASTILLO, Jess, Mr
CLOSA, Maribel, Mrs
CRESPO, Beln, Dr
CUADRAS RAYMI, Elisa, Mrs
DALMASES, Jordi, Mr
DE LA CUERDA, Angel Lus, Mr
DE QUIROGA, Santiago, Mr
DEL OLMO, Patricia, Mrs
DEL RIO CASADO, Javier, Mr
DEMEURE, Thierry, Mr
DAZ MARCOS, Susana, Ms
DAZ VARELA, Raul, Mr
DOS RAMOS FARIAS, Martin, Mr
ENDRNYI, Szilvia, Ms
ESCALERA, Sonia, Mrs
ESCRIBANO, Beln, Mrs
ESTEVE, Albert, Mr & Mrs Marina
ESTEVE, Antoni, Mr
FERNANDEZ, Francisco, Mr
FERRE, Piedad, Mrs
FERRER LOPENZO, Ana Maria, Ms
FONT, Javier, Mr
GALLARDO, Lucia, Mrs
GARCA VAQUERO, Mara Luisa, Mrs
GAVALD, Josep, Mr
GILABERT, Antoni, Mr
GMEZ, Jess, Mr
HERNNDEZ, Csar, Mr
HORTELANO ALMEIDA, Felipe, Mr
INFANTE, Filipe, Dr
INIESTA, Cristina, Mrs
ISBERT, Carmen, Ms
JAN LLORET, Miguel Angel, Mr
JUAN, Sonia, Mrs
LABORDA, Merce, Mrs
LCAR SALDAS, Beatriz, Mrs
LENS, Carlos, Mr
LOPEZ GIL, Meritxell, Mrs
LPEZ, Pilar, Mrs
LPEZ-GIL, Maite, Ms
MADRID, Paloma, Ms
MARCH, Javier, Mr
Almirall
Uriach-Aquilea
Chiesi
Europa Press
GSK Consumer Health Care
Boiron
Luba Consult
Esteve
Chiesi
SENFYC
PMFarma
Correo Farmacutico
Arkopharma
Laboratorios Salvat
Ferrer
GTF
FEFE
GENCAT
Johnson & Johnson
Gaceta Mdica
Spanish Medicines Agency
Zambon
COF Barcelona
AESEG
El Global
Estar Bien
CINFA
Sano
Boiron
AESEG
Bayer Hispania
Gedeon Richter
Lacer
Spanish Medicines Agency
Laboratorios Dr Esteve
Farmindustria
Unidad Editorial
Ministry of Health
Bayer Hispania
Fardi
Informativo FEFAC
AEMPS
COF Barcelona
Catalan Health Service
SEFAC
AEMPS
Angelini
Health Market Research
Public Health Agency
anefp
Almirall
CUS
Cinfa
Ministry of Health
Lab. Dr Esteve
GENCAT
anefp
El Farmacutico
Conference
51
20/05/2015 16:33
MARCOS, Rubn, Mr
MART, Arantxa, Mrs
MARTIN CORTS, Manuel, Mr
MARTN PADILLA, Silvia, Mrs
MARTNEZ MORA, Mara Luisa, Mrs
MASEGOSO ARTEAGA, M Pilar, Ms
MASJUN, Mamen, Ms
MINGUELL FONT, Esther, Mrs
MORENO, Sofa, Mrs
NAVARRO OLIVELLA, Javier, Mr
NORIEGA, Miguel, Mr
NUENO, Pedro, Prof.
OLLEROS, Toms,
ORTZ, Dr & Dr Mrs Ana Isabel
PAPIOL, Cristina, Mrs
PATINHA, Marco, Dr
PELLIS, Laura, Mrs
PREZ PEY, Marc, Mr
PEY, Jaume, Mr
RAMENTOL, Jordi, Mr
REDONDO, Fernando, Mr
RIBADA GRANJA, Alicia, Dr
RICE, Katherine, Mrs
RIESGO, Marta, Mrs El
RIVERO, Agustn, Mr
RODRIGUEZ RIERA, Mariola, Mrs
ROLDN, Tais, Mr
ROVIROSA ESCOSURA, Mario, Mr
RUIZ, Boi, Mr
SBAT SANTANDREU, Eduard, Mr
SALADA, Angel, Mrs
SANGLAS, Helena, Mrs
SANZ, Esther, Mrs
SANZ, Ferran, Prof.
SARD, Jos Mara, Mr
SASTRE, Nuria, Mrs
SEDANO MONASTERIO, Eugeni, Dr
SERRA, Joan, Mr
SISTERNAS, Carlos, Mr
SOLS, Raquel, Ms
SORIANO, Joan, Mr
SUREZ, Mara Luisa, Ms
SUOL, Rosa, Mrs
TORRES, Antonio, Mr
UROSA, Blanca, Mrs
Europa Press
Farmaindustria
Mylan EPD
Ferrer
AEMPS
Almirall
anefp
Zambon
Laboratorios Salvat
Uriach
HRA Pharma
IESE Business School
Grupo Farmasierra
VENEGAS, Cecilio, Mr
VILDA, Javier, Mr
VOSSOS, Konstantinos, Mr
ZABALA ALFONSO, Elena, Mrs
Laboratorios Hartmann
Health Market Research
CRES University Pompeu Fabra
Hartmann
anefp
Ferrer
FEFE
Ferrer
CINFA
Global
Ministry of Health
Lab. Dr. Esteve
RB
Chiesi
Minister of Health Catalonia
Angelini
IM Farmacias
IM Hospitales
IMIM
Johnson & Johnson
anefp
Dr. Esteve
GENCAT
Fenin
anefp
El Pais
AEMPS
Avedis Donabedian Institute
FEFAC
Health Department Madrid Autonomous
Region
Consejo General de Farmacuticos
El Periodico
Zambon
Sweden
BERGLUND, Johan, Mr
NSMAN, Inger, Mrs
McNeil AB
LIF
Switzerland
ALEKXANDROVA, Ioulia,
Mrs & Mr Christian SUBLET
BANGERTER, Martin,
Mr & Mrs Judith BANGERTER-PAETZ
BORRI, Michele, Mr
52
Novartis Consumer Health

Schweizerischer Drogistenverband (SDV)
Vifor
Conference
20/05/2015 16:33
BUENNIG, Frank, Mr
CSELOVSZKY, Kristina, Ms
DELCKER, Andreas, Dr
FUHRER, Hans-Rudolf, Mr & Mrs Martha
GENVE, Sbastien, Dr
GOETSCHMANN, Ursula, Ms
HARTMANN, Urs, Mr
HCHNER, Peter, Mr
HLZLE, Walter, Mr
HUBER, Elisabeth, Ms & Mr Stefan VON GRNIGEN
KANTSPERGER, Christine, Ms
LEHMANN, Urs, Dr S
MABBOUX, Bruno, Dr
MENNET-VON EIFF, Mnica, Dr
OHLE, Joerg, Mr
PESTALOZZI, David, Mr & Mrs Gudrun
SCHAEFER, Ulrich, Dr
SCHORI, Beat, Mr
SCHUHBAUER, Birgit, Mrs
SPNI, Daniel, Mr & Mrs Karina SCHILDKNECHT
STDELI, Walter, Mr
SUSLOVA, Vlada, Ms
SZURAN, Thomas F., Dr
TOMMASI ROSSO, Fabio, Mr
TREPP, Gian, Mr
ZAIDAN, Fadel, Mr
Medinova
DSM Nutritional Products
Galderma - Spirig
ASSGP
Bayer Consumer Care
Interdelta
Bayer Consumer Care
HCI Solutions
vips
Schweizerischer Drogistenverband (SDV)
Bayer Consumer Care
imilasan
PGT Healthcare
Weleda
Bayer Consumer Care
Bio-Strath
HCI Solutions
Sano-aventis
Johnson & Johnson Consumer Europe
Sanatrend
ASMC
Bayer Consumer Care
Biomed
Novintethical
Similasan
PGT Healthcare
The Netherlands
ALBERTS, Nico, Mr
BALMER, Robert, Mr
BEENAERTS, Greet, Mrs & Mr Guido LEYSSENS
BOUWMEESTER, Vincent, Mr
FEDOROVA, Victoria, Mrs
FLUITMAN, Maayke, Mrs
GROEN, Dirk, Mr
HENDRIKS, Maikel, Mr
HOOGENDOORN, Henry, Mr
JONGERIUS, Rutger, Mr
LELIE-VAN DER ZANDE, Rian, Ms
MAURITZ, Bernard, Mr
VAN DIJK, Bauke, Mr
VERSCHUUREN, Niels, Mr
VU, Dzung, Ms
Vemedia
Medical Brands
Bayer
Medical Brands
Medical Brands
care2create
Meda Pharma
Medical Brands
Tjoapack
Archy Consulting
KNMP
Neprofarm
Medical Brands
Patheon
RB
Tunisia
BEN MOHAMED, Ahlem, Mrs
GARALI, Rached, Mr
JALLEL, Abdallah, Mr
JERIBI, Chokri, Mr
KILANI, Rak, Mr
MASMOUDI, Sara, Ms
Direction de la Pharmacie et du Mdicament

Syndicat des Pharmaciens
Conseil de lordre des Pharmaciens
Sano
Teriak
Teriak
Turkey
BAARAN, Ahmet, Mr
OLAK, Erdoan, Mr
KEKLIK, Huseyin Kagan, Mr
KZLAY, Harun, Mr
SATK, Devrim, Mr
SERBEST, Aslihan, Mrs
TATAR, Yavuz, Mr
YUCEL, Erman, Mr
Ministry of Agriculture
Turkish Pharmacists Association
Sano
Sano
Sano
Conference
53
20/05/2015 16:33
United Arab Emirates

ABDEL MALIK, Hany, Dr
KANDIL, Rasha, Mrs
KHALIFA, Anas, Dr
MOHSIN, Adi, Dr
SAWIRIS, Ramez, Mr
SHIYAB, Mejad, Mrs
G
T
N
Mundipharma
Public Health & Safety Department
Bayer Healthcare
Bayer Healthcare
United Kingdom
BASA, Ahmed, Mr
BASSI, Cristina, Ms
BHATT, Aomesh, Dr
BRANCH, Sarah, Dr
BUCKELDEE, Robert, Mr
CALDER-SMITH, Martin, Mr
CALDWELL-NICHOLS, Matthew, Mr
CARPENTER, Glenn, Dr & Mrs Janice
CARR, Alison, Dr
CARTER, Sarah, Ms
CASTLE, Donna, Mrs
CHAMPION, Stephen, Mr
DARRACOTT, Helen, Mrs
DUDLEY, James, Mr
GALLEN, Tom, Mr
GRIFFITHS, Mark B., Dr
HALL, Nicholas, Mr
HAMMOND, Fiona, Ms
HARTNETT, Owen, Mr
KELLY, Sheila, Ms
KINYUA, Chris, Mr
NIETO, Francine, Mrs
OBRIEN, Felim, Mr
PEAD, Filomena, Ms
PITALE, Prasanna, Mr
RICE, Mike, Mr
SCHESKE, Manfred, Mr
SHEPHARD, Toby, Dr
SPEERS, Matthew, Mr
STEWART, Matt, Mr
STIMSON, Nina, Mrs
TISMAN, Andy, Mr
WILKES, Deborah, Mrs & Mr Alaric WATERSON
United States of America
CHILUKURI, Sastry, Mr
CLOUD DUGAN, Noelle, Mrs
COLGAN, Kevin, Mr
COMBE, Christopher, Mr & Mrs Courtney
FIELDING, Jeanette, Mrs
KUSMIEZ, Katazyna, Ms
MCNAMARA, Brian, Mr
MELVILLE, Scott, Mr
MURA, Raquel, Ms
MURPHY, William, Mr
OLOHAN, Ryan, Mr
PAYAWAL, Mariclaire, Ms
SPANGLER, David, Mr
VARMA, Suneet, Mr
Johnson & Johnson

RB
RB
MHRA
nielsen
Communications International Group
Johnson & Johnson
Hamell Communications
OTC Insight Europe
PAGB
PAGB
James Dudley International
OTC Bulletin
Pzer Consumer Healthcare
Nicholas Hall
Hamell Communications
Nicholas Hall
O
O
O
O
At
un
ca
Nicholas Hall
IMS Health
Nicholas Hall
IMS Health
OTC bulletin
inrst Healthcare
Pzer
PAGB
OTC bulletin
Nicholas Hall
IMS Health
OTCToolbox
Fo
pr
tra
he
W
pr
or
hu
an
ch
McKinsey
Combe
Bayer HealthCare
US Pharmacia
CHPA
Sano
Johnson & Johnson
Google
CHPA
Pzer
Status 20 May 2015 (noon)

54
Lin
Conference
20/05/2015 16:33
GOOD OTC
TRAINING KNOWS
NO BOUNDARIES...
OHow well do pharmacists and health
advisors really know your products?
ODo they fully understand all
indications and benefits?
OWhat are the advantages over
unbranded alternatives?
OWhy should they recommend
your product?
At CIG Healthcare Partnership we
understand that professional OTC training
can transform a products sales success.
For nearly 40 years, we have been a leading
provider of specialist multi-award winning
training to major national and international
healthcare retailers and manufacturers.
Whether its structured OTC learning
programmes, pharmacist engagement tools
or multi-language web-based e-learning
hubs, we have the know-how, experience
and talent to create and deliver behaviour
changing knowledge Europe-wide.
Bespoke Training Materials

Publications
Digital Communications
E-learning
Research
Events
Contact Frances Shortland for an exploratory discussion at

frances.shortland@1530.com or +44 (0) 207 534 7222
www.cighealthcare.co.uk
Linen Hall, 162-168 Regent Street, London W1B 5TB
20/05/2015 16:33
52nd AESGP
Annual Meeting
31 May 2016 - 2 June 2016 | Athens
Hotel Divani
Apollon Palace
aesgp.eu/52
aesgp.eu
7 avenue de Tervuren, B-1040 Brussels | Tel: +3227355130 | info@aesgp.eu
20/05/2015 16:33

AESGP Programme

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

AESGP Programme

Uploaded by

Copyright:

Available Formats

Barcelona

26-28 May 2015

AESGP CONFERENCE ON YOUR MOBILE

Available presentations are uploaded at aesgp.eu/p51

Sessions | Speakers and background information

Next AESGP Conferences

Medicines and Medical Devices Data Bank

Food Supplements Data Bank

Get your badge from the AESGP Welcome Desk:

)R\HURIWKH+LOWRQ'LDJRQDO0DU(see floorplan p6)

Consumer Health Industry: how

New technology - new guidance better self-care

Pedro NuenoProfessor in the Department

Brian McNamara, Head of Americas

Global perspectives on Citizen

Self-care medical devices and

Switching: A mega trend?

How to make health care affordable?

The new European Union platform

Jaume Pey,Director General, anefp, Spain

Rosa Suol,Director General, Avedis Donabedian

17:30 End of 1st day

How to ensure availability of

Perspectives for the future

Vincent Warnery, Senior Vice President,

Roger Scarlett-SmithAESGP President

19:00 Closing dinner

Hilton Diagonal Mar

Foyer / Coffee station

Hilton Diagonal Mar

Hilton Diagonal Mar

Tuesday 26 May 2015

Dress code: Business

Casa Llotja de Mar

Wednesday 27 May 2015

Consumer Health Industry: How to provide the best service?

Global perspectives on Citizen Empowerment:

10:30 - 11:00 Break

Wednesday 27 May 2015

New technology - new guidance - better self-care

12:30 - 14:00 Lunch

Compiegne. He spent his entire career in healthcare medical devices,

Wednesday 27 May 2015

How to make health care affordable?

Jaume Pey, Director General, anefp, Spain

Wednesday 27 May 2015

The new European Union platform for the

Rosa Suol, Director General, Avedis Donabedian Institute, Barcelona

17:30 End of 1st day

Thursday 28 May 2015

Self-care medical devices and food supplements:

Hubertus Cranz, AESGP Director General

This includes in particular the legal

EFSA NDA Panel scientific assessment of health claims applications

mance requirements GHPDQGLQJ

Council of the EU (Member States)

,Q FODVV ,,E LQ DOO RWKHU FDVHV LI

As of May 2015, the Council Working

So-called trilogue discussions on a

Thursday 28 May 2015

Switching: A mega trend?

Is the move of medicines from prescription to non-prescription slowing down

Suneet Varma, President, Consumer Healthcare, Pfizer

Thursday 28 May 2015

Pedro NuenoProfessor in the Department

Roger Scarlett-SmithAESGP President